Recent Abstracts

12th International Haemovigilance Seminar
February 17 - 19, 2010 | Dubrovnik, Croatia

1. JC Osselaer, JP Cazenave, W Liu, A Elliot, W Reed, L Lin, L Corash. An Active Hemovigilance Program to Assess the Safety Outcome for 18,641 Platelet Components Tranfused in Multiple European Clinical Sites. 
2. JP Cazenave, JC Osselaer, W Liu, A Elliot, W Reed, L Lin, L Corash. An Active Hemovigilance Program to Assess the Safety Outcome for 32, 480 INTERCEPT Plasma Component Transfusions.[Poster PDF] 
3. Dragoslav Domanovic, Ana Milojkovic, Marko Cukjati, Johannes Irsch, Lily Lin. Hemovigilance of Transfusions with Platelet Treated with INTERCEPT Blood System Using an Active Hemovigilance Program - Data from Slovenia. 
4. F Knutson, H Lof. HV at a University Hospital After Transfusions of Platelets Pathogen Inactivated with the INTERCEPT Technology. 
5. JC Osselaer, B De Coene, MC Thonet, C Corlier, J Jamart, C Doyen. The Incidence of CNS Bleeding in Transfusion Dependent Patients Before and After Introduction of Pathogen Inactivated Platelet Components: A Six-year Hemovigilance Survey.[Poster PDF] 
6. JP Cazenave, D Kientz, I Mendel, H Isola, C Waller. Hemovigilance Surveillance Of Platelet Components Prepared With Pathogen Inactivation Treatment During a Three Year Period.[Poster PDF] 
7. D Kientz, I Mendel, C Waller, H Isola, JP Cazenave. Hemovigilance Surveillance Of Therapeutic Plasma Prepared With Pathogen Inactivation Treatment During a Two Year Period.[Poster PDF]

XXth Regional Congress, Asia, International Society Blood Transfusion
November 14 - 18, 2009 | Nagoya, Japan

1. L Lin and L Corash. An Active Hemovigilance Program to Characterize the Safety Profile of 16,631 Platelet Components Prepared with INTERCEPT Blood System Transfused in Routine Clinical Practice.[Poster PDF] 
2. JP Cazenave, A. Shimosaka, L Corash. Active Hemovigilance of Pediatric Patients Supported with Plasma Components Prepared with Photochemical Treatment (INTERCEPT™).[Poster PDF] 
3. A Shimosaka, JC Osselaer, W Liu, L Lin. Pathogen Inactivation and In Vitro Function of Platelet Components Collected in 100% Plasma Treated with INTERCEPT Blood System
   [Poster PDF]

View more abstracts on the INTERCEPT Product website >